Table S1.

The demographic characteristics of human pathological samples

Sample no.AgeSexPMIDiagnosisOtherRegions given
121552F28ControlN/ATemp, clbm
130185MControlB&B: IIFr, temp, clbm
147792M12ControlB&B: IIFr, temp, clbm
150686M10ControlFr, clbm
154487M48ControlB&B: IFr, clbm
164163M16ControlFr, temp, clbm
156672M25ADFr, temp, clbm
161982M24ControlFr, temp, clbm
40981F15FAM ADCERAD: CFr, temp, clbm
a156790F12ADB&B: V, CERAD: BFr, clbm
158189M22ADB&B: VI, CERAD: BFr, temp, clbm
158772M24ADB&B: VI, CERAD: BFr, temp, clbm
159179F30ADB&B: VI, CERAD: BFr, temp, clbm
159883M27ADB&B: VI, CERAD: BFr, temp, clbm
160293F15ADB&B: V, CERAD: BFr, temp, clbm
160469F24ADB&B: VI, CERAD: CFr, temp, clbm
162089M14ADB&B: IV, CERAD: BFr, temp, clbm
  • All samples were from white subjects. B&B, Braak stage; CERAD, Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery; Clbm, cerebellum; F, female; FAM, familial; Fr, frontal cortex; M, male; N/A, clinical diagnosis was not obtained; PMI, postmortem interval; temp, temporal lobe.